Skip to content

Evaluation of Interests of FIT Therapy on Diabetics Children Insulin-dependent

Evaluation of Interests of the Functional Insulin Therapy (FIT Therapy) on Metabolic Control, Hypoglycemia Prevention and Life Quality of Diabetics Children Insulin-dependent Treated With Insulin Pump.

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01443741
Acronym
DIABFIT
Enrollment
88
Registered
2011-09-30
Start date
2012-01-31
Completion date
2015-07-31
Last updated
2011-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Insulin Dependent

Keywords

FIT Therapy, Diabetes mellitus, Insulin pump, Pediatric

Brief summary

Evaluation of interests of the functional insulin therapy (FIT Therapy) on metabolic control, hypoglycemia prevention and life quality of diabetics children insulin-dependent treated with insulin pump.

Detailed description

Open multicenter randomized study of one year, evaluating two groups of 44 children with diabetes mellitus (diabetes over 1 year) treated with insulin pump, one group by traditional way (fixed doses of insulin and meals providing stable quantities complex carbohydrates) and the other group by FIT Therapy.

Interventions

OTHERTherapeutic education

Specific program for FIT Therapy and specific program for traditional way

Sponsors

University Hospital, Angers
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* aged 1-17 years * diabetic for at least 1 year * whose HbA1c is between 7.6 and 10% (7.6% \<HbA1C \<10%) * treated with insulin pump * agreeing to perform at least three blood glucose/day * willing to follow the treatment with functional insulin therapy if necessary

Exclusion criteria

* Ages \<1 year or\> 17 years * Duration of diabetes \<1 year * HbA1c \<7.6% or HbA1c\> 10% * Treatment-by multiple injections * Mental disability * Refusal to adhere to the constraints of the study * Language barrier, preventing any understanding or cooperation * Eating behavior-type anorexia or bulimia * Pregnancy * Use of alcohol or drugs * Severe chronic or genetic pathology other than diabetes * Participation in another clinical study or refusal to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Variation in HbA1cOne yearVariation in HbA1c from baseline in the study (M0) and 1 year later the beginning of the program (M12) for assess the importance of the FIT Therapy to improve metabolic control of children with diabetes mellitus treated with subcutaneous insulin pump.

Secondary

MeasureTime frameDescription
Severe hypoglycemia over 6 months and quality of lifeOne year and six monthsNumber of severe hypoglycemia over 6 months (M6 to M12 and evolution of quality of life assessed by validated questionnaries in children with diabetes (WHO questionnary items 5, 27 KIDSCREEN questionnary, DISABKID questionnary).

Countries

France

Contacts

Primary ContactRégis Coutant, MD PhD
ReCoutant@chu-angers.fr33(2)41-35-56-55
Backup ContactNatacha Bouhours-Nouet, MD
NaBouhours-Nouet@chu-angers.fr33(2)41-35-44-06

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026